Packing: – 10X10
M.R.P: – 790
NIZBRO consists of Acebrophylline capsule is a medication used to treat and prevent asthma and chronic obstructive lung disease. Acebrophylline is a bronchodilator and a mucolytic. It works by relaxing the muscles of the airways as well as thinning and loosening mucus, making breathing easier.
It is a bronchodilator and mucolytic drug used to treat asthma and chronic obstructive lung disease symptoms (COPD). Acebrophylline is a mucolytic and bronchodilator that acts by relaxing the muscles of the airways as well as thinning and loosening mucus, making breathing easier. Acebrophylline includes ambroxol, which aids in several stages in the creation of pulmonary surfactant, as well as theophylline-7 acetic acid, whose carrier role elevates blood levels of ambroxol, thereby swiftly and intensively promoting surfactant formation.
Take Acebrophylline capsule with a normal meal with water to avoid any kind of stomach upset. Take this medicine twice a day, for better results. But doctor’s consultancy is essential before taking this medication.
If the patient is allergic to Acebrophylline, theophylline, or other related drugs. If the patient has renal or liver issues. If the patient has a cardiac condition, such as low blood pressure, unstable blood pressure, or an irregular heart rhythm.
Acebrophylline Capsules may concern the patient since this may cause some side effects. However, if the patient experiences any kind of unusual side effects then let the doctor know. Diarrhoea, dizziness, heartburn, nausea, vomiting, skin rash, stomach discomfort, or drowsiness. These are some of the common side effects which will disappear once the body is adapted to the medicine.
Soigner Pharma, one of the major pharma businesses, has made an indelible impact on the industry. The firm is ISO accredited and works as per the norms set by WHO and GMP. Soigner Pharma is a well-known Acebrophylline Capsules manufacturer and supplier, as well as a provider of PCD Pharma Franchise for Acebrophylline Capsules. We provide exclusive rights and profitable services to franchise businesses. To balance the quantity and quality of the products, we make them in an efficient manufacturing lane.
ACEBROPHYLLINE HAS 3 ACTIONS NAMELY BRONCHODILATION, MUCOREGULATION & ANTI-INFLAMMATORY ACTION.
A.)PHARMACODYNAMICS: Acebrophylline inhibits intracellular phosphodiesterase associated significantly reduce
airway inflammation and obstruction in chronic stages. Acebrophylline increases the synthesis and release of alveolar surfactant, resulting in triple action: mucoregulation, stimulation of bronchoalveolar clearance, and anti-inflammatory-interactive effect. In patients with chronic obstructive bronchitis, given the drug for 10-20 days, there was a good reduction in expectorating Viscosity. With cAMP levels and facilitates bronchial muscles relaxation. Acebrophylline selectively inhibits phosphatidylcholine and phospholipase A, TNF-alpha and leukotrienes. Inhibition of such pro-inflammatory mediators can.
• Absorption: – 200mg oral acebrophylline, the two components of the molecule ambroxol and theophylline-7-acetic acid are released in the stomach and absorbed in the intestine, reaching optimal concentrations of ambroxol within 2hrs and of theophylline-7-acetic acid after 1 hr.
• Half-Life: – The plasma half-life varies from 4 to 9 hrs after oral administration.
• Metabolism: – The drug is metabolized in the liver and eliminated really.
Indications: Treatment of adult patients with COPD and bronchial asthma.